Bpost International Pharmaceutical Import Profile — Belgium (DGFT 2022–2026)

Name: Bpost International Pharmaceutical Import Records from India — 5 Products, $977.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Bpost International — Pharmaceutical Importer Profile (2026) | 5 Products, $977.8K Trade | TransData Nexus

Bpost International

Pharmaceutical Importer · Belgium · Diabetes & Endocrine Focus · $977.8K Total Trade · DGFT Verified

Bpost International is a pharmaceutical importer based in Belgium with a total trade value of $977.8K across 5 products in 2 therapeutic categories. Based on 1,642 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Bpost International sources from 2 verified Indian suppliers, with Lawrence Walter accounting for 100.0% of imports.

Bpost International — Import Portfolio & Supplier Network

Bpost International import network — 5 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Bpost International?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Lawrence Walter	$1.4M	9,988	100.0%
Gaia Trade Private Limited	$370	12	0.0%

Bpost International sources from 2 verified Indian suppliers across .

What Formulations Does Bpost International Import?

Formulation	Value	Ships
Rifagut 550MG (rifaximin) size-100	$63.3K	38
Rifagut 550MG rifaximin size-100	$55.6K	28
Apigat 5MG apixaban size-30	$49.7K	30
Rifagut 550MG (rifaximin) size-10	$48.6K	36
Apigat 5MG (apixaban) size-30	$46.5K	39
Rifagut 550MG rifaximin size-10	$36.5K	27
Restasis %0.05 0.4ML cyclosporin	$28.3K	20
Ivabid 5MG (ivabradine) size-14	$26.3K	37
Rpigat 20MG (rivaroxaban) size-30	$25.0K	33
Motivyst 300MG (canagliflozin) size-30	$23.6K	36
Rifagut 550MG rifaximin size 100 tabs packs batch no gkd1935a mfg date nov 22exp date oct 24 pharmaceuticals	$21.1K	7
Apigat 5MG apixaban size 30 tabs packsbatch no 1903226 mfg date nov 22 exp date oct 25 pharmaceuticals	$18.9K	9
Ivabid 5MG ivabradine size-14	$17.4K	23
Rpigat 20MG rivaroxaban size-30	$16.5K	25
Mesacol 800MG (mesalamine) size-15	$14.1K	34

Bpost International imports 1,670 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 5 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Empagliflozin	Diabetes & Endocrine	$696.9K	716	10.4%	2
2	Semaglutide	Advanced Diabetes Medications	$163.1K	331	3.3%	9
3	Canagliflozin	Advanced Diabetes Medications	$68.2K	227	7.7%	3
4	Linagliptin	Advanced Diabetes Medications	$48.3K	341	1.2%	6
5	Saxagliptin	Advanced Diabetes Medications	$1.3K	27	0.0%	15

Bpost International imports 5 pharmaceutical products across 2 categories into Belgium totaling $977.8K.

Bpost International — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Bpost International is a division of Bpost, Belgium's leading postal operator, responsible for the delivery of national and international mail. Established in 1830, Bpost has evolved into a comprehensive logistics and e-commerce services provider, connecting consumers, businesses, and government entities through mail and parcel delivery. The company is headquartered in Brussels, Belgium, and operates a network of 2,300 service points, including post offices, parcel lockers, and pick-up points, ensuring extensive reach across the country.

Bpost International plays a pivotal role in Belgium's pharmaceutical distribution network by importing finished pharmaceutical formulations from India. These imports encompass a range of products, primarily focusing on diabetes and endocrine medications. The company's strategic sourcing from India underscores its commitment to providing a diverse and reliable supply of pharmaceutical products to meet the healthcare needs of the Belgian population.

2Distribution Network

Bpost International leverages Bpost's extensive infrastructure to facilitate the import and distribution of pharmaceutical products. With a network of 2,300 service points across Belgium, including post offices, parcel lockers, and pick-up points, Bpost ensures efficient delivery and accessibility of imported pharmaceuticals. The company's logistics capabilities are further enhanced by its international presence, allowing for streamlined cross-border shipments and timely delivery to various regions within Belgium.

3Industry Role

In Belgium's pharmaceutical supply chain, Bpost International functions as a primary wholesaler and importer, sourcing finished pharmaceutical formulations from India. By focusing on diabetes and endocrine medications, Bpost International addresses specific therapeutic needs within the Belgian market. Its role is crucial in ensuring a steady supply of these specialized products, contributing to the overall efficiency and reliability of the pharmaceutical distribution network in Belgium.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Bpost International

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Bpost International's sourcing strategy exhibits a high degree of concentration, with a significant reliance on a single supplier, Lawrence Walter, accounting for 100% of the shipments. This single-source dependency may pose risks related to supply chain disruptions, pricing fluctuations, and potential challenges in negotiating favorable terms. The absence of alternative suppliers indicates a strategic choice to maintain consistency and quality in product offerings. However, this approach also underscores the need for robust contingency planning and risk management strategies to mitigate potential vulnerabilities associated with such concentrated sourcing.

2Supply Chain Resilience

The resilience of Bpost International's Indian supply chain is contingent upon the stability and reliability of its sole supplier, Lawrence Walter. The lack of backup suppliers and the high concentration of shipments with a single source may expose the company to risks such as supply disruptions, regulatory changes, or geopolitical issues affecting trade routes. Additionally, the diversity of formulations imported, with 1,670 unique formulations, suggests a complex supply chain that may benefit from diversification strategies to enhance resilience and mitigate potential risks.

Strategic Implications

Importing Pharmaceuticals into Belgium — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Belgium

1Regulatory Authority & Framework

In Belgium, the Federal Agency for Medicines and Health Products (FAMHP) is the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. Key legislation governing pharmaceutical imports includes the Royal Decree of 14 December 2006, which outlines the conditions for the importation of medicinal products, and the Law of 25 March 1964, which regulates the pharmaceutical profession. The marketing authorization pathway for Indian generics involves obtaining approval from the FAMHP, ensuring compliance with European Union standards and regulations.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in Belgium necessitate that importers hold a valid wholesale distribution authorization issued by the FAMHP. Additionally, imported products must be accompanied by a Good Manufacturing Practice (GMP) certificate recognized by the European Union, WHO, or PIC/S. This ensures that imported pharmaceuticals meet the stringent quality standards required for distribution within Belgium and the broader European market.

3Quality & Labeling

Bpost International — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Bpost International's focus on importing diabetes and endocrine medications aligns with the growing prevalence of these conditions in Belgium. The market demand for such products is driven by an aging population and increasing awareness of endocrine disorders. By concentrating on these therapeutic areas, Bpost International addresses a critical segment of the healthcare market, ensuring the availability of essential medications to meet patient needs.

2Sourcing Profile

Bpost International's sourcing strategy emphasizes the procurement of generic drugs, particularly in the diabetes and endocrine categories. The company's preference for finished pharmaceutical formulations over raw APIs or bulk drugs indicates a focus on ready-to-use products that meet European quality standards. India's established pharmaceutical manufacturing capabilities and adherence to international GMP standards make it a suitable partner for Bpost International's procurement needs.

3Market Positioning

Based on its product mix, Bpost International serves the wholesale distribution segment of the Belgian pharmaceutical market. By importing and distributing essential medications, the company plays a crucial role in ensuring that retail pharmacies, hospitals, and other healthcare providers have access to necessary pharmaceutical products. Its strategic focus on specific therapeutic areas allows it to cater effectively to the needs of the Belgian healthcare system.

Seller's Guide — How to Become a Supplier to Bpost International

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Bpost International by offering complementary products or services that align with the company's existing portfolio. Identifying gaps in Bpost International's current sourcing, such as unmet demand for specific formulations or innovative drug delivery systems, can provide avenues for collaboration. Establishing relationships with Bpost International may require navigating the regulatory landscape and ensuring compliance with Belgian and European Union standards.

2Requirements & Qualifications

Indian exporters seeking to supply Bpost International and the Belgian market must obtain a valid wholesale distribution authorization from the FAMHP. Products must be accompanied by a GMP certificate recognized by the European Union, WHO, or PIC/S. Additionally, compliance with batch testing, stability requirements, and labeling standards in Dutch and French is mandatory. Serialization mandates must also be met to facilitate traceability and prevent counterfeit products.

3How to Approach

Frequently Asked Questions — Bpost International

What products does Bpost International import from India?

Bpost International imports 5 pharmaceutical products across 2 categories. Top imports: Empagliflozin ($696.9K), Semaglutide ($163.1K), Canagliflozin ($68.2K), Linagliptin ($48.3K), Saxagliptin ($1.3K).

Who supplies pharmaceuticals to Bpost International from India?

Bpost International sources from 2 verified Indian suppliers. The primary supplier is Lawrence Walter (100.0% of imports, $1.4M).

What is Bpost International's total pharmaceutical import value?

Bpost International's total pharmaceutical import value from India is $977.8K, based on 1,642 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Bpost International focus on?

Bpost International imports across 2 categories. The largest: Diabetes & Endocrine (71.3%), Advanced Diabetes Medications (28.7%).

Get Full Bpost International Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.